Vogmeri MF G 2mg/500mg/0.3mg Tablet
Marketer
Merlyn Biotech
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Vogmeri MF G 2mg/500mg/0.3mg Tablet
Diabexe Trio 2mg/500mg/0.3mg tablets are classified as antidiabetic medications. This triple-combination therapy treats type 2 diabetes in adults by regulating blood glucose. Diabexe Trio should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with well-managed blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight control as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, characterized by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential for prevention. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headaches, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, will be recommended by your doctor.
Primary Ingredients of Vogmeri MF G 2mg/500mg/0.3mg Tablet
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Vogmeri MF G 2mg/500mg/0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Vogmeri MF G 2mg/500mg/0.3mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Vogmeri MF G 2mg/500mg/0.3mg Tablet should be administered on an empty stomach.
Common Side effects of Vogmeri MF G 2mg/500mg/0.3mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Vogmeri MF G 2mg/500mg/0.3mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the Vogmeri MF G 2mg/500mg/0.3mg Tablet whole; avoid chewing, crushing, or fracturing. Consumption should be on an empty stomach.
How Vogmeri MF G 2mg/500mg/0.3mg Tablet works:
Each Vogmeri MF G tablet (2mg/500mg/0.3mg) contains a triple-action blend of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Vogmeri MF G 2mg/500mg/0.3mg Tablets is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Vogmeri MF G 2mg/500mg/0.3mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against the risks before prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Vogmeri MF G 2mg/500mg/0.3mg tablets is likely inadvisable. Preliminary research in humans indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyUNSAFE
Employing Vogmeri MF G 2mg/500mg/0.3mg tablets in individuals with kidney disease carries a high likelihood of adverse effects and is best avoided. Patients should seek medical advice before use. This medication is particularly unsuitable for those with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Vogmeri MF G 2mg/500mg/0.3mg tablets cautiously, as dose modification may be necessary. Individuals with mild to moderate liver disease should typically begin with a low dose; however, its use is contraindicated in those with severe hepatic dysfunction. Consult a physician for guidance.
What if you forget to take Vogmeri MF G 2mg/500mg/0.3mg Tablet :
Should you forget to take your Vogmeri MF G 2mg/500mg/0.3mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vogmeri MF G 2mg/500mg/0.3mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently